Cite
HARVARD Citation
Metzger, M. et al. (2021). Excellent Outcome for Pediatric Patients With High-Risk Hodgkin Lymphoma Treated With Brentuximab Vedotin and Risk-Adapted Residual Node Radiation. Journal of clinical oncology. 39 (20), pp. 2276-2283. [Online].